TREATMENT OF BRAIN METASTASES OF LUNG-CANCER WITH HIGH-DOSES OF ETOPOSIDE (VP16-213) - COOPERATIVE STUDY FROM THE GROUPE FRANCAIS PNEUMO-CANCEROLOGIE

被引：30
|
作者：
KLEISBAUER, JP
VESCO, D
OREHEK, J
BLAIVE, B
CLARY, C
POIRIER, R
SARETTO, S
CARLES, P
DONGAY, G
GUERIN, JC
MARTINAT, Y
机构：
[1] HOP PASTEUR,F-06031 NICE,FRANCE
[2] CTR HOSP AIX EN PROVENCE,AIX EN PROVENCE,FRANCE
[3] HOP PURPAN,TOULOUSE,FRANCE
[4] HOP LA CROIX ROUSSE,LYON,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 02期
关键词：
D O I：
10.1016/0277-5379(88)90243-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / &
相关论文
共 32 条
  • [1] VP16-213 INFUSIONS FOR THE TREATMENT OF METASTATIC LUNG-CANCER
    STEWARD, WP
    THATCHER, N
    SHIU, W
    WAGSTAFFE, J
    CROWTHER, D
    [J]. BRITISH JOURNAL OF CANCER, 1983, 48 (01) : 117 - 118
  • [2] PHASE-3 STUDIES WITH ETOPOSIDE (VP16-213) IN LUNG-CANCER PATIENTS
    ISSELL, BF
    ROSENBAUM, PF
    DHAFIR, RA
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 239 - 239
  • [3] Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer:: A Groupe Francais de Pneumo-Cancerologie Study
    Thomas, P
    Castelnau, O
    Paillotin, D
    Léna, H
    Robinet, G
    Muir, JF
    Delaval, P
    Gouva, S
    Balmes, P
    Blanchon, F
    Perdu, D
    Poirier, R
    de Santi, PP
    Penot-Ragon, C
    Kleisbauer, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1320 - 1325
  • [4] LUNG CANCER IN PATIENTS UNDER 40 YEARS: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY (GROUPE FRANCAIS DE PNEUMO-CANCEROLOGIE (GFPC) 1001 STUDY)
    Bigay-Game, L.
    Bota, S.
    Greillier, L.
    Monnet, I.
    Madroszyk, A.
    Corre, R.
    Mastroianni, B.
    Falchero, L.
    Chouaid, C.
    Audigier-Valette, C.
    Baize, N.
    Daniel, C.
    Fraboulet, G.
    Gossot, D.
    Raynaud, C.
    Mazieres, J.
    Colineaux, H.
    Lepage, B.
    Robinet, G.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [5] Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer:: a Groupe Francais de Pneumo-Cancerologie Study
    Thomas, P
    Robinet, G
    Ferri-Dessens, RM
    Léna, H
    Gouva, S
    Vernejoux, JM
    Kleisbauer, JP
    [J]. LUNG CANCER, 2002, 36 (02) : 191 - 198
  • [6] TREATMENT OF SMALL CELL LUNG-CANCER USING THE CYCLOPHOSPHAMIDE AND VP16-213 COMBINATION
    LARRIBA, JLG
    ALVAREZ, YE
    DEPAREDES, MLG
    PEREZ, MAD
    GALLEGO, AO
    GARCIA, JMM
    [J]. BULLETIN DU CANCER, 1983, 70 (03) : 214 - 214
  • [7] DOXORUBICIN, CYCLOPHOSPHAMIDE AND VP16-213 (ACE) IN THE TREATMENT OF SMALL CELL LUNG-CANCER
    AISNER, J
    WHITACRE, M
    VANECHO, DA
    WESLEY, M
    WIERNIK, PH
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 187 - 193
  • [8] TREATMENT OF SMALL CELL LUNG-CANCER WITH A COMBINATION OF VP16-213 AND CYCLOPHOSPHAMIDE WITH CISPLATIN OR RADIOTHERAPY
    FUNES, HC
    DOMINGUEZ, P
    TORRUBIA, AP
    LANZOS, E
    MENDEZ, M
    MENDIOLA, C
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 181 - 186
  • [9] RANDOMIZED STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATINUM IN NON-SMALL CELL LUNG-CANCER
    FUKS, JZ
    AISNER, J
    VANECHO, DA
    SCHIPPER, H
    LEVITT, M
    OSTROW, S
    WIERNIK, PH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (05) : 295 - 301
  • [10] BRAIN METASTASES OF LUNG-CANCER - EXCESSIVE TOXICITY OF HIGH-DOSE VP-16-213
    VIENS, P
    LAGRANGE, JL
    THYSS, A
    AYELA, P
    FRENAY, M
    SCHNEIDER, M
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (12): : 1905 - 1906
1234